Huntington's Gene Therapy Shows 75% Slower Disease Progress

A groundbreaking gene therapy called AMT-130 has slowed Huntington's disease progression by 75% in clinical trials, offering hope to families who've waited 154 years for effective treatment.

The one-time treatment could preserve patients' ability to walk, speak, and connect with loved ones for years longer.